XML 72 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period at Dec. 30, 2016 $ 89,318 $ 290 $ 2,072,591 $ (416) $ (1,983,147)
Balance at beginning of period (in shares) at Dec. 30, 2016   289,924      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 154,227       154,227
Net unrealized gains (losses) on available-for-sale securities, net of tax impact of $(1,049), $156, and $0, respectively 69     69  
Issuance of common stock under equity incentive and stock purchase plans (in shares)   5,408      
Issuance of common stock under equity incentive and stock purchase plans 17,409 $ 5 17,404    
Issuance of common stock on exercise of warrants (in shares)   877      
Issuance of common stock on exercise of warrants 0 $ 1 (1)    
Stock-based compensation 23,938   23,938    
Balance at end of period (in shares) at Dec. 29, 2017   296,209      
Balance at end of period at Dec. 29, 2017 284,961 $ 296 2,114,184 (347) (1,829,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 690,070       690,070
Net unrealized gains (losses) on available-for-sale securities, net of tax impact of $(1,049), $156, and $0, respectively (354)     (354)  
Issuance of common stock under equity incentive and stock purchase plans (in shares)   3,667      
Issuance of common stock under equity incentive and stock purchase plans 13,411 $ 4 13,407    
Stock-based compensation $ 40,626   40,626    
Balance at end of period (in shares) at Dec. 28, 2018 299,876 299,876      
Balance at end of period at Dec. 28, 2018 $ 1,287,453 $ 300 2,168,217 (701) (880,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 321,012       321,012
Net unrealized gains (losses) on available-for-sale securities, net of tax impact of $(1,049), $156, and $0, respectively 3,770     3,770  
Issuance of common stock under equity incentive and stock purchase plans (in shares)   4,955      
Issuance of common stock under equity incentive and stock purchase plans 17,133 $ 5 17,128    
Stock-based compensation $ 56,602   56,602    
Balance at end of period (in shares) at Jan. 03, 2020 304,831 304,831      
Balance at end of period at Jan. 03, 2020 $ 1,685,970 $ 305 $ 2,241,947 $ 3,069 $ (559,351)